Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Richardson-Vicks was a prominent American consumer goods company specializing in over-the-counter pharmaceuticals and personal care products. The company is most recognized for its Vicks brand, which includes iconic products such as VapoRub, NyQuil, and DayQuil. In addition to its respiratory health portfolio, Richardson-Vicks owned several major beauty and skincare brands, including Oil of Olay, Pantene, and Clearasil. The company was formed in 1981 following the divestiture of the ethical pharmaceutical business of its predecessor, Richardson-Merrell. In 1985, Richardson-Vicks was acquired by Procter & Gamble for approximately $1.24 billion after a hostile takeover attempt by Unilever. Today, its brands continue to be core components of Procter & Gamble's global healthcare and beauty divisions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Richardson-Vicks.